Defunct Company
Total Trials
12
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,400
NCT02446054
A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus Disease
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2014
Completion: Dec 31, 2015
NCT02342743
Open-trial on the Prevention of Chronic Migraines With the CEFALY Device
Start: Feb 2, 2015
Completion: Apr 11, 2017
NCT02411513
Acute Treatment of Migraine Using the CEFALY Device
Phase: Phase 1
Start: Apr 30, 2015
Completion: Not specified
NCT02616978
Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
Start: Nov 30, 2015
NCT02546362
Cefaly® Device in the Treatment of Patients With Fibromyalgia.
Start: Dec 3, 2015
Completion: May 15, 2018
NCT02590939
Acute Treatment of Migraine With e-TNS
Start: Feb 1, 2016
Completion: Mar 31, 2017
NCT03217968
Abortive Treatment of Migraine With the Cefaly® Abortive Program Device
Start: Aug 10, 2017
Completion: Jan 10, 2018
NCT03465904
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Start: Apr 10, 2018
Completion: Jan 11, 2019
NCT03811093
Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss
Start: Jan 21, 2019
Completion: Feb 9, 2019
NCT05638165
A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
Start: Oct 13, 2021
Completion: Nov 20, 2021
NCT06393088
Clinical Trial of the invisaRED® IR REHAB Device When Used as an Adjunctive Therapy for Nociceptive Musculoskeletal Pain
Start: Jul 22, 2024
Completion: Aug 30, 2024
NCT06788977
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy
Start: Nov 25, 2024
Completion: Dec 31, 2030